Ambys Medicines Funding: $107M Raised, Series A (2021)

Ambys Medicines is based in South San Francisco, California, Country. It has raised $107M in total funding. Latest round: Series A.

Ambys Medicines funding overview

Ambys Medicines is based in South San Francisco, California, Country. Ambys Medicines has raised $107M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in December 2021. The round record for Ambys Medicines runs through 2021; nothing later has been disclosed. Investors on record include Third Rock Ventures, Takeda, Alexandria. 3 distinct backers are named across the disclosed rounds.

Ambys Medicines at a glance

Total raised
$107M
Latest round
Series A
Latest round date
December 2021
Headquarters
South San Francisco, California, Country
Notable investors
Third Rock Ventures, Takeda, Alexandria

Frequently asked about Ambys Medicines funding

How much has Ambys Medicines raised?
Ambys Medicines has raised $107M in total disclosed funding across the rounds on record.
Who has invested in Ambys Medicines?
Third Rock Ventures, Takeda, Alexandria are named among the investors backing Ambys Medicines.
What was the latest Ambys Medicines funding round?
The most recent disclosed round is a Series A, announced in December 2021.
Where is Ambys Medicines based?
Ambys Medicines is based in South San Francisco, California, Country.
When did Ambys Medicines last raise?
The last disclosed Ambys Medicines round closed in December 2021 at Series A.

Every Ambys Medicines figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.

Companies related to Ambys Medicines (34)

Browse related funding lists (4)

Company funding database · Investor directory · Founder database · Mega-rounds 2026